• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

heart drug

An image taken by the Weill Cornell Medicine research lab that has discovered how the heart drug perhexiline maleate can dest
Research

Heart drug sheds light on potential pancreatic cancer therapy

Scientists have shown that an old heart drug can inhibit growth of one of the most common forms of pancreatic cancer, at least in preclinical models. 
Helen Floersh Jan 2, 2024 6:30am
blood pressure heart stethoscope

Windtree's shock med rapidly raises blood pressure—and shares

Apr 20, 2022 10:38am
heart surgery catheter hospital surgeon

Bristol Myers drug helps patients avoid heart procedures

Apr 2, 2022 9:30am
heart model

AstraZeneca, Ionis ink $2.9B biobucks deal for heart drug

Dec 29, 2021 10:03am
Brooklyn Bridge

BridgeBio CEO calls phase 3 failure of heart drug 'baffling'

Dec 28, 2021 8:35am
Stop watch

BMS heart drug delayed as risk mitigation program worked out

Nov 19, 2021 8:55am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings